All the research on one disease. One report. Updated for 12 months.
Every option that’s been studied — including the small advances that improve daily life — each with its source and evidence level. The full picture is yours; the decision, you make with your doctor.
Between the diagnosis and “take this,” research often holds more.
studied for a different use, showing real benefit in early research.
with initial evidence — and the interactions to know before combining anything.
recruiting right now, that few patients ever hear about.
Examples of what research can hold — not promises. Every option in a report carries its source and evidence level, to discuss with your doctor.
12+ research portals across America, Europe, Russia, Asia, Africa & Oceania












Three ways patients get let down — and the fourth option.
Ten minutes, one drug
No time to cover what else exists, what to avoid, or what’s in the pipeline.
Confident, but partial
Ask once and rare diseases fall through the cracks — with no way to see what it missed.
Real stories, buried
Genuine experience mixed with guesswork, impossible to verify on your own.
One sourced picture
Everything worth knowing, sorted by evidence, every claim cited — and kept up to date.
Every report, the same rigorous shape.
Not an improvised answer — a consistent structure that covers a disease from every side, in plain language.
What it is & why it happens
The mechanism behind the disease, explained so you can actually follow it.
Treatments, by evidence
Each option tagged established, experimental or anecdotal — no false certainty.
What to be careful with
Supplements, foods and drugs that may interact badly or make things worse. Safety information — not a nudge to start anything.
Trials & what’s on the horizon
Open trials and research in development, honestly staged — “early, not yet proven.”
The research doesn’t stop. Neither do we.
Once a disease is under watch, we keep scanning and alert you only when the evidence genuinely changes — a new trial, a new study, a new guideline. At most once a week. Often less. Always real.
Built to be checked, not just believed.
Trusted only
PubMed, Cochrane, ClinicalTrials.gov, Orphanet and guidelines. No forums, no ad-ranked pages.
Every claim cited
Open the source behind any statement. Professional clinical review is the upgrade we’re building toward.
No pharma, no ads
Nothing to sell but the research itself. We’re building toward nonprofit status.
About the limits
Information about a disease — not medical advice, not a diagnosis, not personalized to you.
“The study that finally helped me had been published for three months before I found it — and I search for information for a living. The answer existed. Nobody handed it to me. No patient should have to wait like that.”
Starting where patients are most under-served.
We begin with conditions where the need is high and good information is scarce — and we’re adding more.
One plan. The report, plus a year of watching.
- The full structured report, every claim cited
- Twelve months of real evidence alerts
- A living report with its own changelog
Latest research, trials and guides.
Nav1.7 in erythromelalgia: what changed
A plain-language look at recent Nav1.7 research in erythromelalgia: what studies found, how strong the evidence is, and what it doesn't prove yet.
What our evidence labels mean
Not all medical findings carry equal weight. Here's what the three evidence labels mean, and why we tag every treatment in a report with one of them.
How to read a clinical trial as a patient
A short, practical guide to understanding a clinical trial: phases, what the results really mean, and the questions worth bringing to your doctor.
Walk into your doctor’s office already knowing the right questions.
A thorough, sourced, up-to-date picture of a disease — including what to be careful with, and what isn’t proven yet.
See a sample report →